Chabiotech Co.,Ltd. (085660.KQ) has a MoatMap StockRank of 21/100 based on Quality (25/100), Value (48/100), and Momentum (33/100) factor scores. The current signal is SELL.
Chabiotech Co.,Ltd., a bio company, develops cell and gene therapy related to stem and immune cells in South Korea and internationally.
| Price | $7.56 |
| Market Cap | $595M |
| Price/Book | 2.88 |
| Return on Equity | -14.1% |
| Return on Invested Capital | -7.2% |
| Debt/Equity | 93.52 |
| Gross Margin | 27.6% |
| Operating Margin | -9.3% |
| Revenue Growth | 8.4% |
| Free Cash Flow | $-113K |
Chabiotech Co.,Ltd. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).